These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8323172)

  • 1. New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome.
    Hall JE; Taylor AE; Martin KA; Crowley WF
    Ann N Y Acad Sci; 1993 May; 687():182-92. PubMed ID: 8323172
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of gonadotropin secretion in man.
    Boyar RM
    Med Clin North Am; 1978 Mar; 62(2):367-73. PubMed ID: 25360
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
    Cheung AP; Lu JK; Chang RJ
    Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.
    Tarlatzis BC; Grimbizis G
    J Assist Reprod Genet; 1997 Jan; 14(1):1-4. PubMed ID: 9013299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective LH hypergonadotropism - pre, peri and postmenopausal forms.
    Geller S; Ayme Y; Dajoux R; Balozet J; Olivier G; Lemasson C; Scholler R
    Acta Eur Fertil; 1981 Sep; 12(3):281-3. PubMed ID: 6803500
    [No Abstract]   [Full Text] [Related]  

  • 10. Pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.
    Cheung AP; Chang RJ
    Hum Reprod; 1995 May; 10(5):1054-9. PubMed ID: 7657740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
    Vulkov I
    Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
    [No Abstract]   [Full Text] [Related]  

  • 12. The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.
    Lobo RA; Shoupe D; Chang SP; Campeau J
    Am J Obstet Gynecol; 1984 Feb; 148(4):423-8. PubMed ID: 6364811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
    Baskind NE; Balen AH
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of gonadotropin response to luteinizing hormone--releasing hormone in amenorrheic women.
    Crosignani PG; Reschini E; D'Alberton A; Trojsi L; Cantalamessa L; Giustina G
    Am J Obstet Gynecol; 1974 Oct; 120(3):376-84. PubMed ID: 4607337
    [No Abstract]   [Full Text] [Related]  

  • 15. Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?
    Berga SL; Daniels TL
    Semin Reprod Endocrinol; 1997 May; 15(2):169-75. PubMed ID: 9165660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropins in polycystic ovarian syndrome.
    Fauser BC; De Jong FH
    Ann N Y Acad Sci; 1993 May; 687():150-61. PubMed ID: 8323170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycystic ovary syndrome or Stein-Leventhal syndrome: findings and prospectives].
    Molinatti GM; Limone P
    Minerva Endocrinol; 1987; 12(3):175-8. PubMed ID: 3116378
    [No Abstract]   [Full Text] [Related]  

  • 18. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat.
    Simard M; Brawer JR; Farookhi R
    Biol Reprod; 1987 Jun; 36(5):1229-37. PubMed ID: 3113503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine regulation of the secretion of gonadotropins in the polycystic ovary syndrome].
    Massobrio M; Guidetti D
    Minerva Endocrinol; 1987; 12(3):191-4. PubMed ID: 3116380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.